$AZN Company News Drug makers face another $65 billion

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$AZN Company News

Drug makers face another $65 billion patent cliff 12:42 p.m. Dec. 10, 2014 - Russ Britt
Eli Lilly, AstraZeneca launch patient trial for Alzheimer's treatment 7:19 a.m. Dec. 1, 2014 - Tomi Kilgore
AstraZeneca advances in London; pound rises as inflation ticks up 11:59 a.m. Nov. 18, 2014 - Carla Mozee
AstraZeneca forecasts revenue of $45 bln by 2023 2:43 a.m. Nov. 18, 2014 - MarketWatch.com
FDA revokes Ranbaxy’s right to generic versions of Nexium, Valcyte 11:05 a.m. Nov. 6, 2014 - Sean McLain
AstraZeneca lifts 2014 guidance as profit slides 2:33 a.m. Nov. 6, 2014 - MarketWatch.com
Pfizer sales fall less than expected 6:34 a.m. Oct. 28, 2014 - MarketWatch.com
Eli Lilly's sales hit again by patent expirations 5:59 a.m. Oct. 23, 2014 - MarketWatch.com
3 stocks Ken Fisher likes 10:09 a.m. Oct. 21, 2014 - Insider Monkey
FTSE 100 teetering on edge of correction; Shire sinks in London 12:13 p.m. Oct. 15, 2014 - Carla Mozee
Is the AbbVie-Shire deal dead? Stock market thinks so 6:05 a.m. Oct. 15, 2014 - Sara Sjolin
FTSE 100 falls amid broader European selloff 11:02 a.m. Oct. 7, 2014 - Sara Sjolin
TNT Express slumps; Rio Tinto climbs: Europe’s stock movers 11:12 a.m. Sept. 24, 2014 - Sara Sjolin
Rio Tinto, Vodafone lift FTSE 100 for first day in three 11:11 a.m. Sept. 24, 2014 - Sara Sjolin
Pfizer held takeover talks with Actavis 12:33 a.m. Sept. 24, 2014 - Jonathan D. Rockoff
CF Industries rises on merger talks; AstraZeneca, AbbVie fall 2:21 p.m. Sept. 23, 2014 - Sue Chang
Burger King, AbbVie among stocks hit by new tax inversion rules 1:41 p.m. Sept. 23, 2014 - Ben Eisen
Eli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment 6:17 a.m. Sept. 16, 2014 - Tomi Kilgore
Lilly to pay AstraZeneca up to $500 mln as part of Alzheimer's treatment agreement 6:04 a.m. Sept. 16, 2014 - Tomi Kilgore
Eli Lilly, AstraZeneca agree to co-develop Alzheimer's treatment 6:03 a.m. Sept. 16, 2014 - Tomi Kilgore


Update: AstraZeneca Wins EU Approval For Lynparza 1:13 a.m. Today - Seeking Alpha
Tax Inversions Wrap Up 3:01 p.m. Dec. 18, 2014 - Seeking Alpha
AstraZeneca cancer drug cleared in Europe 7:22 a.m. Dec. 18, 2014 - Seeking Alpha
Is A Dividend Cut The End Of The World? Analysis Of Dividend-Cutting Companies, Part I 6:04 p.m. Dec. 17, 2014 - Seeking Alpha
Meet 5 Big Tech Stocks Expected To See Profits Surge 8:03 p.m. Dec. 16, 2014 - Investors Business Daily
Theravance Biopharma Pipeline Valuation 7:43 a.m. Dec. 16, 2014 - Seeking Alpha
Money flow surges in AstraZeneca 10:38 a.m. Dec. 11, 2014 - Seeking Alpha
Nektar/AstraZeneca's Moventig Gets EU Approval for OIC - Analyst Blog 6:50 p.m. Dec. 10, 2014 - Zacks.com
Merck's Keytruda Might Treat Virulent Breast Cancer 10:04 a.m. Dec. 10, 2014 - Investors Business Daily
AstraZeneca (AZN) Moving On Heavy Volume In The Pre-Market Hours 9:24 a.m. Dec. 10, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NBIX TECH AZN ISIS 7:30 a.m. Dec. 10, 2014 - InvestorPlace.com
Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog 6:20 p.m. Dec. 9, 2014 - Zacks.com
Update: AstraZeneca Wins EU Approval For Moventig 2:46 p.m. Dec. 9, 2014 - Seeking Alpha
Take the Risk for Reward With Pfizer Options 9:00 a.m. Dec. 9, 2014 - InvestorPlace.com
Moventig cleared in Europe for OIC 7:14 a.m. Dec. 9, 2014 - Seeking Alpha
Actavis' Antibiotic Backed for FDA Approval, Response in Q1 - Analyst Blog 6:30 p.m. Dec. 8, 2014 - Zacks.com
Assessing The Magnitude Of Pfizer's Coming Dividend Increase 3:11 p.m. Dec. 8, 2014 - Seeking Alpha
Seattle Genetics down on ASH presentations 12:37 p.m. Dec. 8, 2014 - Seeking Alpha
Dynavax to initiate asthma trial 10:55 a.m. Dec. 8, 2014 - Seeking Alpha
Time To Focus On What's Good 4:59 p.m. Dec. 7, 2014 - Seeking Alpha


Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4:01 p.m. Dec. 11, 2014 - PR Newswire - PRF
Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4:01 p.m. Nov. 25, 2014 - PR Newswire - PRF
AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center 11:08 a.m. Nov. 21, 2014 - BusinessWire - BZX
Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies 11:37 a.m. Nov. 19, 2014 - PR Newswire - PRF
Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 1:33 p.m. Nov. 18, 2014 - PR Newswire - PRF
AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting 9:00 a.m. Nov. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4:01 p.m. Nov. 11, 2014 - PR Newswire - PRF
Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk 9:05 a.m. Nov. 11, 2014 - PR Newswire - PRF
U.S. FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes 6:05 a.m. Oct. 30, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 4:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Ardelyx's Tenapanor Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2014 9:30 a.m. Oct. 23, 2014 - PR Newswire - PRF
AstraZeneca Launches Fit2Me™, a Free Customized Diet and Lifestyle Support Program for People with Type 2 Diabetes 6:31 a.m. Oct. 15, 2014 - BusinessWire - BZX
Branding Campaign, Asset Sale, Executive Promotion, Clinical Data Presentation, and Drug Approval Update - Research Reports on Synchrony Financial, Avalonbay, Aflac, Teva and AstraZeneca 7:35 a.m. Oct. 7, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 8:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza 10:34 a.m. Sept. 15, 2014 - PR Newswire - PRF
Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza 7:09 a.m. Sept. 15, 2014 - PR Newswire - PRF
Publishing of Clinical Study Data, Employee Recognition, Market Activity, Investment in Infrastructure - Research Reports on AstraZeneca, Northrop Grumman, Corning, PPL Corp. and Edison 8:10 a.m. Sept. 11, 2014 - PR Newswire - PRF
Trialbee Helps AstraZeneca Reduce the Time Required for Recruitment of Patients to Clinical Trials 6:32 a.m. Sept. 10, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 8:20 a.m. Sept. 3, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 25

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 19

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 19

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 16

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 80

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 88

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 30

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 5

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 37

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading

Top 5 Most Recently Viewed Articles

Homrich Berg Welcomes Tim Tallach as New Tax Director

Updated Category News Views 319

Homrich Berg Welcomes Tim Tallach as Director Atlanta-based Homrich Berg, a prominent fee-only wealth advisor recognized for its comprehensive services, proudly announces the addition of Tim Tallach, J.D., CPA, as its new Director of Advanced Tax Planning and Family Office Services. This important addition to the team aims to fortify the firm's capabilities in serving...

Continue Reading
G-III Apparel Group Schedules First Quarter Earnings Call

Updated Category News Views 168

G-III Apparel Group Prepares for Earnings Announcement G-III Apparel Group, Ltd. (NASDAQ: GIII) is a prominent entity in the global fashion industry, recognized for its innovative design, sourcing, and marketing capabilities. The company has recently made an announcement regarding its first quarter fiscal 2026 earnings. This significant event is scheduled to take place...

Continue Reading
Mediaplanet's Initiative to Empower Small Businesses Nationwide

Updated Category News Views 117

Mediaplanet's Campaign for Small Business Success Small businesses play a pivotal role in stimulating the economy by fostering innovation, generating employment, and enhancing community engagement. However, in the face of today's complex business challenges, many entrepreneurs require support to navigate these waters successfully. To address this need, Mediaplanet has...

Continue Reading
New Barclays Report Highlights AI's Impact on Data Centre Demand

Updated Category News Views 529

Revolutionizing Data Centres: Insights from Barclays Research In a groundbreaking report, Barclays Research reveals that the rising influence of artificial intelligence (AI) could propel data centre usage in the US to triple by 2030. This report, titled “AI revolution: Meeting massive AI infrastructure demands,” presents a comprehensive analysis of how AI's growth...

Continue Reading
Major Renovation Completed at Aloft Phoenix-Airport Hotel

Updated Category News Views 274

Aloft Phoenix-Airport Unveils Major Renovation In an exciting development for travelers, the Aloft Phoenix-Airport has completed a comprehensive renovation that significantly upgrades its facilities. This 143-room hotel, managed by HEI Hotels & Resorts and owned by The RADCO Companies, has refreshed everything from guest rooms to public spaces, ensuring a modern and...

Continue Reading